Tim Kutzkey - Net Worth and Insider Trading

Tim Kutzkey Net Worth

The estimated net worth of Tim Kutzkey is at least $7 Million dollars as of 2024-05-15. Tim Kutzkey is the Director, 10% Owner of Surrozen Inc and owns about 627,652 shares of Surrozen Inc (SRZN) stock worth over $7 Million. Details can be seen in Tim Kutzkey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tim Kutzkey has not made any transactions after 2024-04-04 and currently still holds the listed stock(s).

Transaction Summary of Tim Kutzkey

Tim Kutzkey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tim Kutzkey owns 9 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .

Click here to see the complete history of Tim Kutzkey’s form 4 insider trades.

Insider Ownership Summary of Tim Kutzkey

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2021-08-18	10 percent owner
NGM	NGM Biopharmaceuticals Inc	2019-08-07	10 percent owner & other: Managing Partner
NRIX	Nurix Therapeutics Inc	2021-05-07	10 percent owner
		2020-11-16	10 percent owner
		2020-03-19	10 percent owner & other: Managing Partner
		2019-04-02	10 percent owner & other: Managing Partner
		2018-03-14	10 percent owner
		2024-04-04	director & 10 percent owner
		2021-08-11	director & 10 percent owner

Tim Kutzkey Latest Holdings Summary

Tim Kutzkey currently owns a total of 1 stock. Tim Kutzkey owns 627,652 shares of Surrozen Inc (SRZN) as of April 4, 2024, with a value of $7 Million.

Latest Holdings of Tim Kutzkey

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SRZN	Surrozen Inc	2024-04-04	627,652	10.45	6,558,650

Holding Weightings of Tim Kutzkey

Tim Kutzkey Form 4 Trading Tracker

According to the SEC Form 4 filings, Tim Kutzkey has made a total of 2 transactions in Surrozen Inc (SRZN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Surrozen Inc is the acquisition of 193,548 shares on April 4, 2024, which cost Tim Kutzkey around $3 Million.

Insider Trading History of Tim Kutzkey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tim Kutzkey Trading Performance

GuruFocus tracks the stock performance after each of Tim Kutzkey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tim Kutzkey is %. GuruFocus also compares Tim Kutzkey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tim Kutzkey within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tim Kutzkey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tim Kutzkey

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-11.74
Relative Return to S&P 500(%)	-11.36

Tim Kutzkey Ownership Network

Ownership Network List of Tim Kutzkey

No Data

Ownership Network Relation of Tim Kutzkey

Tim Kutzkey Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Tim Kutzkey is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, Tim Kutzkey made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 39,000 shares made by William Ho , a net sale of 1,640 shares made by Dirk G. Brockstedt , and a net purchase of 5,000 shares made by Wendye Robbins .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,640 shares of RAPT Therapeutics Inc (RAPT) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 35,640 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

Tim Kutzkey is the 10 percent owner & other: Managing Partner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include 10 percent owner Column Group L P , director & 10 percent owner David V Goeddel , and Chief Financial Officer Jean-frederic Viret .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, Tim Kutzkey made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 1,830,051 shares made by Column Group L P , a net purchase of 614,197 shares made by David V Goeddel , and a net sale of 85,082 shares made by Jin-long Chen .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,082 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 2,444,248 shares were bought by its insiders, resulting in a net purchase of 2,359,166 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Tim Kutzkey is the 10 percent owner of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include Chief Financial Officer Houte Hans Van , General Counsel Christine Ring , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Tim Kutzkey made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 31,786 shares made by Houte Hans Van , a net sale of 10,406 shares made by Gwenn Hansen , and a net sale of 7,455 shares made by Christine Ring .

In summary, during the past 3 months, insiders sold 15,218 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 15,218 shares. During the past 18 months, 50,413 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 50,413 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nurix Therapeutics Inc Insider Transactions

No Available Data

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Tim Kutzkey is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include Chief Financial Officer Jack Anders , director & See Remarks Mark A Goldsmith , and General Counsel Jeff Cislini .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Tim Kutzkey made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 91,644 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .

In summary, during the past 3 months, insiders sold 68,164 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 68,164 shares. During the past 18 months, 337,190 shares of Revolution Medicines Inc (RVMD) were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 312,810 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Tim Kutzkey is the 10 percent owner & other: Managing Partner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Immune Design Corp do?

Who are the key executives at Immune Design Corp?

Tim Kutzkey is the 10 percent owner & other: Managing Partner of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .

Immune Design Corp (IMDZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Design Corp Insider Transactions

No Available Data

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Tim Kutzkey is the 10 percent owner of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include See Remarks Jennifer Jarrett , director & 10 percent owner & President Juan C. Jaen , and 10 percent owner Gilead Sciences Inc .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, Tim Kutzkey made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 38,443 shares made by Juan C. Jaen , and a net sale of 8,506 shares made by Goeltz Ii Robert C. .

In summary, during the past 3 months, insiders sold 110,657 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 110,657 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcus Biosciences Inc Insider Transactions

No Available Data

What does Surrozen Inc do?

Who are the key executives at Surrozen Inc?

Tim Kutzkey is the director & 10 percent owner of Surrozen Inc. Other key executives at Surrozen Inc include 10 percent owner Column Group Iii Gp, Lp , Exec. Vice President & Research Yang Li , and director & 10 percent owner Blutt Mitchell J Md .

Surrozen Inc (SRZN) Insider Trades Summary

Over the past 18 months, Tim Kutzkey made 2 insider transaction in Surrozen Inc (SRZN) with a net purchase of 387,096. Other recent insider transactions involving Surrozen Inc (SRZN) include a net purchase of 387,096 shares made by Column Group Iii Gp, Lp , a net sale of 5,382,499 shares made by Blutt Mitchell J Md ,

In summary, during the past 3 months, insiders sold 0 shares of Surrozen Inc (SRZN) in total and bought 774,192 shares, with a net purchase of 774,192 shares. During the past 18 months, 358,833 shares of Surrozen Inc (SRZN) were sold and 774,192 shares were bought by its insiders, resulting in a net purchase of 415,359 shares.

Surrozen Inc (SRZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surrozen Inc Insider Transactions

No Available Data

What does Consonance-HFW Acquisition Corp do?

Who are the key executives at Consonance-HFW Acquisition Corp?

Tim Kutzkey is the director & 10 percent owner of Consonance-HFW Acquisition Corp. Other key executives at Consonance-HFW Acquisition Corp include other: Former Director Christopher Haqq , Chief Scientific Officer Wen-chen Yeh , and other: Former VP Business Development House Joshua Cory .

Consonance-HFW Acquisition Corp (CHFW.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Consonance-HFW Acquisition Corp (CHFW.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Consonance-HFW Acquisition Corp (CHFW.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Consonance-HFW Acquisition Corp (CHFW.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Consonance-HFW Acquisition Corp Insider Transactions

No Available Data

Tim Kutzkey Mailing Address

Above is the net worth, insider trading, and ownership report for Tim Kutzkey. You might contact Tim Kutzkey via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Discussions on Tim Kutzkey

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.